Now four years into a first-in-class FDA approval for certain HR-positive, HER2-negative early breast cancers, Eli Lilly’s Verzenio has proven it can extend patients’ lives in the indication. Verzenio ...
Verzenio is the first contemporary therapy in over two decades to demonstrate a significant overall survival benefit in adjuvant HR+, HER2−, high-risk early breast cancer Seven-year results from the ...
Verzenio is the first contemporary therapy in over two decades to demonstrate a significant overall survival benefit in adjuvant HR+, HER2−, high-risk early breast cancer. Seven-year results from the ...
INDIANAPOLIS - Eli Lilly and Company (NYSE:LLY), a prominent player in the pharmaceuticals industry with a market capitalization of $735 billion and impressive revenue growth of 37% over the last ...
If there’s one Royal couple that seems to be going strong, it’s Prince Harry and Meghan Markle. Even as rumors swirl about ...
INDIANAPOLIS - Eli Lilly and Company (NYSE:LLY), a prominent player in the pharmaceutical industry with a market capitalization of $748 billion, will present the primary overall survival analysis from ...
Eli Lilly's CDK4/6 inhibitor Verzenio reduced the risk of death by 15.8% when used as adjuvant treatment for early-stage HR-positive, HER2-negative breast cancer, according the reveal of data from the ...
Lily Allen's 'West End Girl' is a portrayal of modern love and loss that's made listeners reassess their own experiences ...
McDonald’s has announced a BTS TinyTAN Happy Meal collaboration, launching September 3 The collection features two sets of toys: a “Throwback” and an “Encore” edition A “Magic Meetup” event is also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback